STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease.
Francesco BoveDanilo GenoveseMartina PetraccaTommaso TufoDanila PisaniMaria Rita Lo MonacoAnna Rita BentivoglioPaolo CalabresiCarla PianoPublished in: NPJ Parkinson's disease (2022)
The aims of this study were to assess the incidence rate and risk factors for sialorrhea in the long-term follow-up in a cohort of 132 patients with advanced Parkinson's disease [88 with deep brain stimulation (DBS) and 44 on medical treatment]. The incidence rate of sialorrhea did not differ between the two groups; male sex, Hoehn and Yahr stage and dysphagia resulted risk factors for sialorrhea. These findings indicate that DBS does not increase the risk of developing sialorrhea.